As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The ...

Guggenheim analyst Yatin Suneja downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a $20 price target Published first on TheFly – ...

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by Guggenheim from a “buy” rating to a “neutral” rating ...

In the digital realm, the guggenheim-bilbao.eus website recorded a total of 2.893.452 visits and 10.850.342 page views in ...

Investing.com -- Guggenheim named Madison Square Garden Sports Corp (NYSE:MSGS) its "best idea" for 2025 given strong secular ...

Guggenheim Active Allocation Fund (NYSE:GUG – Get Free Report) shares fell 0.5% during trading on Wednesday . The company traded as low as $14.78 and last traded at $14.87. 191,595 shares changed ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

(128.9 × 194.9 cm). Solomon R. Guggenheim Museum, New York, Solomon R. Guggenheim Founding Collection 49.1184. Photo: Kristopher McKay, Solomon R. Guggenheim Museum, New York The ambitious ...

Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the ...

Naomi Beckwith, who holds a leadership role at the Guggenheim Museum in New York, said she would make navigating crises a ...

Guggenheim named MSG Entertainment (MSGE) as a best idea entering 2025. Shares have slid about 23% since fiscal Q1 earnings in November due to ...

Guggenheim New York is an icon of adventurous originality. Experience special exhibitions in our iconic, spiraling rotunda, plus highlights from our collection by Picasso, Degas, and Van Gogh.